The antioxidant tempol, which previously was shown to decrease vascular MMP-2 activity in hypertension [28], prevented calponin-1 loss in 2K-1C hypertensive rats, possibly by decreasing MMP-2 S-glutathionylation [18]. Here, CNN1 is linked to hypertensive disorder.